To test whether NEK2, CKS2, UHRF1, DLGAP5, and FAM83D could be used as diagnostic biomarkers for BC, their expression levels, survival rate and diagnostic ability were evaluated. This evidence concerns the gene DLGAP5 and breast cancer.